Carnival Group International Holdings Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:Carnival Group International Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C0891
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Carnival Group International Holdings Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Carnival Group International Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Carnival Group International Holdings Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Carnival Group International Holdings Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Carnival Group International Holdings Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Carnival Group International Holdings Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Carnival Group International Holdings Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for Carnival Group International Holdings Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Carnival Group International Holdings Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CAPITAL RAISING 11
Capital Raising – Overview 11
Capital Raising – Deal reports 12
Divestments – Deal reports 43
APPENDIX 49
Contact Us 49
About MarketLine Financial Deals Database 49
Deal Definition and Methodology 51
About MarketLine 58

List of Tables
Table 1: Carnival Group International Holdings Limited M&A volume and value trend (2014-YTD2018)
Table 2: Carnival Group International Holdings Limited M&A activity by geography (2014-YTD2018)
Table 3: Carnival Group International Holdings Limited capital raising volume and value trend (2014-YTD2018)
Table 4: Carnival Group International Holdings Limited capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Carnival Group International Holdings Limited M&A volume and value trend (2014-YTD2018)
Figure 2: Carnival Group International Holdings Limited M&A activity by geography (2014-YTD2018)
Figure 3: Carnival Group International Holdings Limited capital raising volume and value trend (2014-YTD2018)
Figure 4: Carnival Group International Holdings Limited capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Carnival Group International Holdings Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Jones Packaging Inc:企業の戦略的SWOT分析
    Jones Packaging Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Imbalie Beauty Limited:企業の戦略・SWOT・財務情報
    Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report Summary Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Taageer Finance Co (TFCI):企業の財務・戦略的SWOT分析
    Taageer Finance Co (TFCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Daewoong Pharmaceutical Co Ltd (069620):企業の財務・戦略的SWOT分析
    Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Pacgen Life Science Corp (PBS)-製薬・医療分野:企業M&A・提携分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. Its products include amino-acid antimicrobia …
  • Titan Petrochemicals Group Ltd (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務分析
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Great Southern Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-医療機器分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • China Billion Resources Limited:企業の戦略・SWOT・財務情報
    China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report Summary China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Etam Developpement SCA:戦略・SWOT・企業財務分析
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Brookfield Asset Management Inc.:企業の戦略・SWOT・財務分析
    Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is develope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆